Skip to Main Content

Paper Details

Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies.
Vaccine
31
2021
B cell, BCDT, CD19, CD20, COVID, COVID mRNA, COVID-19, COVID-19 mRNA, IgM, MS, NMO, RBD, RBD antibody, anti-nucleocapsid antibody, anti-spike RBD, central nervous system autoimmune demyelinating diseases, lymphocyte counts, mRNA, multiple sclerosis, neuromyelitis optica, participants, patients, spike
Author NameAffiliation
Qi WuUniversity of Michigan Medical School
Qi WuUniversity of Michigan Medical School
Gregory A PolandMayo Clinic and Foundation
  • 1 - 3

Datasets

Release 1.2